Chemogenomics can be defined as the study of genomic responses to chemical compounds. The goal is the rapid identification of novel drugs and drug targets embracing multiple early phase drug discovery technologies ranging from target identification and validation, over compound design and chemical synthesis to biological testing and ADME profiling.

[edit] See also

• Genomics
  • Structural genomics
  • Pharmacogenetics
  • Pharmacogenomics
  • Toxicogenomics
• Bioinformatics
• Cheminformatics
  • Computational chemistry
  • Molecular modelling
  • QSAR
• Proteochemometrics

[edit] References

• Chemogenomics in Drug Discovery: A Medicinal Chemistry Perspective, H. Kubinyi (Editor), G. Müller (Editor), R. Mannhold (Series Editor), G. Folkers (Series Editor), Wiley-VCH, 2004.ISBN 3-527-30987-X

[edit] External links

• Kubinyi's slides

v • d • e Topics in Medicinal Chemistry ADME · Bioavailability · Chemogenomics · Drug design · Drug discovery · Enzyme inhibitor · Mechanism of action · New chemical entity · Pharmacodynamics · Pharmacokinetics · Pharmacology · Pharmacophore · Quantitative structure-activity relationship

v • d • e Genomics topics Genome project · Paleopolyploidy · Glycomics · Human Genome Project · Proteomics · Metabolomics · Chemogenomics · Structural genomics · Pharmacogenetics · Pharmacogenomics · Toxicogenomics · Computational genomics · Bioinformatics · Cheminformatics · Systems biology

This pharmacology-related article is a stub. You can help Wikipedia by expanding it. v • d • e